KLRS — Kalaris Therapeutics, Inc.

KLRSKalaris Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · kalaristx.com

4.970USD-3.31%Mkt Cap: 119.15M USDP/E: —Last update: 2026-06-01

Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a clinical-stage anti-vascular end…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap119.15M USD

Enterprise Value27.81M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-43.44M USD

Revenue/Share—

Last Price4.970 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees20

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-3.34

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B1.53

EPS (TTM)-0.79

EPS (Forward)-1.58

52W Range

2.14029% of range11.88

52W High11.88 USD

52W Low2.140 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-55.11%

ROA-35.68%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-38.37M USD

CapEx (TTM)200.00K USD

FCF Margin—

FCF Yield—

Net Debt-97.22M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.02

Current Ratio12.19

Quick Ratio12.03

Book Value/Sh3.441 USD

Cash/Share4.098 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:23

Split DateJan 16, 2025

Analyst Consensus

Rating—

Target (Mean)18.75 USD

Target Range7.000 USD – 25.00 USD

# Analysts8

Ownership

Shares Out.23.79M

Float6.57M

Insiders9.90%

Institutions78.16%

Short Interest

Short Ratio7.9d

Short % Float9.66%

Short % Out.3.38%

Shares Short804.37K

Short (prev mo.)842.69K

Technical

SMA 505.723 (-13.2%)

SMA 2006.554 (-24.2%)

Beta—

S&P 52W Chg27.94%

Avg Vol (30d)83.10K

Avg Vol (10d)76.48K

Technical Indicators

RSI (14)45.5

MACD-0.2320

MACD Signal-0.3288

MACD Hist.+0.0969

BB Upper5.548 USD

BB Middle5.058 USD

BB Lower4.568 USD

BB Width19.39%

ATR (14)0.4156 USD

Vol Ratio (20d)0.48x